|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Dietmar Siemssen||CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board||1,62M||S.O.||1963|
|Dr. Bernd Metzner||CFO & Member of the Management Board||1,09M||S.O.||1970|
|Dr. Lukas Burkhardt||Member of the Management Board||1,09M||S.O.||1979|
|Ms. Katja Schnitzler||Member of Supervisory Board||106k||S.O.||1981|
|Ms. Carolin Nadilo||Corp. Director of Investor Relations||S.O.||S.O.||S.O.|
|Mr. Jens KÃ¼rten||Group Sr. Director of Communication & Marketing and Press Officer of Corp. Media||S.O.||S.O.||S.O.|
|Mr. Helmut Schweiger||MD & GM of Gerresheimer Horsovsky Tyn Plant||S.O.||S.O.||S.O.|
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in DÃ¼sseldorf, Germany.
L’ISS Governance QualityScore de Gerresheimer AG en date du 1 juillet 2021 est 4. Les scores principaux sont Audit : 5; Société : 6; Droits des actionnaires : 1; Compensation : 1.